MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01768nam a2200229Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
NULRC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250520103015.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
250520s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781108749060 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
NULRC |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
R 855.3 .B87 2020 |
| 245 #4 - TITLE STATEMENT |
|---|
| Title |
The Business of healthcare innovation / |
| Statement of responsibility, etc. |
edited by Lawton Robert Burns |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Third Edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Cambridge, United Kingdom : |
| Name of publisher, distributor, etc. |
Cambridge University Press, |
| Date of publication, distribution, etc. |
c2020 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
492 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
25 cm. |
| 365 ## - TRADE PRICE |
|---|
| Price amount |
USD35 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. Product suppliers in the health care value chain Lawton Robert Burns -- 2. The pharmaceutical sector Richard T. Evans and Scott Hinds -- 3. The biotechnology sector - therapeutics Cary G. Pfeffer -- 4. New venture creation in biotechnology Jason Rhodes and Lawton Robert Burns -- 5. The medical device sector Kurt H. Kruger and Max A. Kruger -- 6. Financing medtech innovation Justin Klein -- 7. The healthcare information technology sector Adam C. Powell and John Glaser. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Perhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional |
| Linkage |
.3 billion in funding for the National Institutes of Health (NIH) and other agencies |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
BUSINESS FORECASTING |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books |
